Morgan Stanley (MS) Chief Risk Officer sells 8,500 shares around $182

Rhea-AI Filing Summary

Morgan Stanley Chief Risk Officer Charles A. Smith reported selling common stock in a recent insider transaction. On January 20, 2026, he sold 8,500 shares of Morgan Stanley common stock at a weighted average price of $182.0807 per share. The filing notes that these shares were sold in multiple trades at prices ranging from $182.0401 to $182.1301.

After this sale, Smith reported owning 119,127.619 shares of Morgan Stanley common stock directly. He also reported an indirect holding of 5,494.73 shares through a 401(k) plan. The filing states that detailed trade-by-trade pricing information is available upon request from Morgan Stanley, its security holders, or the SEC staff.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH CHARLES A

(Last) (First) (Middle)

C/O MORGAN STANLEY

1585 BROADWAY

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MORGAN STANLEY [ MS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Risk Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/20/2026		S		8,500	D	$182.0807(1)	119,127.619	D
Common Stock								5,494.73	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $182.0401 to $182.1301, inclusive. The Reporting Person undertakes to provide to Morgan Stanley, any security holder of Morgan Stanley, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Martin M. Cohen, Attorney-in-Fact	01/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Morgan Stanley (MS) report for Charles A. Smith?

The filing reports that Chief Risk Officer Charles A. Smith sold 8,500 shares of Morgan Stanley common stock on January 20, 2026.

At what price did Charles A. Smith sell Morgan Stanley (MS) shares?

The shares were sold at a weighted average price of $182.0807 per share, in multiple trades between $182.0401 and $182.1301.

How many Morgan Stanley (MS) shares does Charles A. Smith hold after the sale?

After the reported sale, Charles A. Smith beneficially owned 119,127.619 shares of Morgan Stanley common stock directly.

Does Charles A. Smith have any indirect holdings of Morgan Stanley (MS) stock?

Yes. The filing shows an indirect holding of 5,494.73 shares of Morgan Stanley common stock by a 401(k) plan.

What does the weighted average price mean in this Morgan Stanley (MS) Form 4?

The filing explains that the $182.0807 figure is a weighted average price for shares sold in multiple transactions between $182.0401 and $182.1301.

Can investors get detailed trade prices for this Morgan Stanley (MS) insider sale?

Yes. The footnote states the reporting person will provide full trade-by-trade price information upon request to Morgan Stanley, any security holder, or SEC staff.